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Abstract
Prevalence of Bovine viral diarrhea virus (BVDV) (“detected” test results) among all bovine samples tested at the
Utah Veterinary Diagnostic Laboratory from 2008 - 2013 was calculated, and results were compared by age, sex, or
breed of the cattle and BVDV diagnostic test methods. Necropsies were tested for BVDV when lesions suggestive of
infection were identified. Adults, juveniles and most calves were tested by antigen (Ag) capture ELISA, while fetuses
and some calves were tested by real-time reverse transcriptase PCR. Cattle originated from Utah and surrounding
states. Chi-square analyses were used to test for significant differences in BVDV prevalence between age, sex,
breed and test methods. Bovine viral diarrhea virus was detected in 105/8,975 samples (1.2%), including 22/180
necropsies (12.2%). Detection of BVDV by each test method was: Ag Capture ELISA-skin 79/7,692 (1.0%); Ag
Capture ELISA-serum 19/1,195 (1.6%); PCR 7/88 (8.0%). Detection of BVDV by age, sex, breed was: male 5/215
(2.3%); female 9/382 (2.4%); fetus 3/36 (8.3%); calf (1-200 days old) 29/579 (5.0%); juvenile (201-729 days old)
4/183 (2.2%); adult (≥ 730 days old) 4/75 (5.3%); dairy 25/750 (3.3%); beef 26/1,600 (1.6%). There were no
significant differences in BVDV detection by age or sex. Necropsied animals (P<0.0001), those tested with PCR
(P<0.0001) and dairy breeds (P=0.07), were more likely to be detected with BVDV. When prevalence of BVDV has
been reported over the last 20 years, it has focused on the 0.1% prevalence of persistently infected (PI) cattle, but
PI cattle are a source of infection for large numbers of herdmates. The 8% prevalence in aborted fetuses and overall
prevalence of >1% demonstrates that despite the low reported prevalence of persistently infected cattle, BVDV
remains an important bovine disease.
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Introduction
Bovine viral diarrhea virus (BVDV) infection is a costly disease of
beef and dairy cattle [1-6]. Statistical modeling estimated the cost of
BVDV in beef cow-calf herds in which infections were present at $90
per cow [3]. A 2003 review from Denmark estimated losses from
BVDV at between $10 and $40 per dairy cow calving [6]. A Canadian
study of direct BVDV costs including abortion and reproductive loss,
milk loss, premature voluntary culling, reduced slaughter value, and
mortality, estimated annual costs at more than $48 mean per cow [2]
across all dairy cows, similar to cost estimates in a US study [5].
Most cattle infected with BVDV acquire transient infections, nearly
all of which are non-fatal and result in seroconversion and immunity
within 14 days [7,8]. The vast majority of these transient BVD
infections are caused by viral shedding from herdmates that were
persistently infected (PI) during gestation [7,8]. Fetuses infected with
BVDV in utero between 30 and 120 days of gestation (while fetal
immunity is being developed) develop immunotolerance and most
become PI [7]. Viral replication persists in these PI animals throughout
their lives. Many PI animals are eventually exposed to a strain of
BVDV different from, or that is a mutation of the strain that caused in
utero infection and subsequently develop severe clinical signs (mucosal
disease) [7,8]. Effects of BVDV infection include gastrointestinal
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disease, respiratory disease, immunosuppression, infertility, abortions,
congenital defects, stillbirths and lost meat and milk production [7,9].
BVDV has been reported throughout the world [10]. It is estimated
that 0.13% of cattle in the US are PI [11].
This descriptive case series reports the proportion of detection of
BVDV in all samples tested for the disease at the Utah Veterinary
Diagnostic Laboratory (UVDL) in the Intermountain West over a 4½year period.

Materials and Methods
All samples/specimens included in this descriptive case series were
of bovine origin and were tested for BVDV at the Utah Veterinary
Diagnostic Laboratory (UVDL) from November 2008 through April
2013. Cattle originated from Utah and surrounding states. Blood,
serum, and ear notch or other skin biopsy samples were submitted for
BVDV testing in variably sized groups, nearly always without an
accompanying history of whether or not there were clinical signs
suggestive of infection with BVDV. Such testing was often required for
interstate or international shipment of animals and/or for testing for
the presence of PI animals within commercial herds, driven by the
interest of the owners. These samples were representative of cattle from
the study area.
Necropsied cattle (including non-mummified fetuses) or tissues
submitted from field necropsies to the UVDL were tested for BVDV
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when lesions suggestive of infection were identified. In fetuses, such
lesions include microencephaly, cerebellar hypoplasia, cataracts,
arthrogryposis, hydrocephalus, myelination defects, microphthalmia,
thymic aplasia, hypotrichosis, brachygnathism, hydranencephaly, or
pulmonary hypoplasia. In calves, juveniles and adults (see age groups
below), BVDV-associated lesions include vasculitis, rumenitis,
reticulitis, omasitis, abomasitis, crypt or gland centered enterocolitis,
ulcers in any part of the digestive tract, or lymphoid depletion of
Peyer’s patches and/or lymph nodes.

Age groups
Age of tested animals was not provided for every submission. Where
age was provided, animals were classified as: fetuses, calves (1-200 days
old), juvenile (201-729 days old), and adult ≥ 730 days old. Similarly,
sex or breed was not always provided, especially for samples submitted
in large groups. When provided, sex and/or breed were recorded. Some
animals were described by the submitter as simply “Beef ” breeds. For
animals necropsied at the laboratory, sex was recorded and breed was
also if it was readily apparent, e.g., purebred Holstein, Charolais, etc.

Test methods for BVDV
Antigen capture ELISA-skin (Bovine Viral Diarrhea Antigen Test
Kit, IDEXX, Inc., Westbrook, ME) was performed on ear notches or
other skin biopsy samples according to the manufacturer’s instructions.
Ear notches or skin biopsy samples were soaked in phosphate-buffered
saline (PBS) for a minimum of 10 min at room temperature, but where
logistics allowed, they were soaked overnight in PBS at 4°C to facilitate
viral antigen diffusion into PBS. When testing >20 samples, postincubation PBS was placed into non-antigen coated, low protein
binding microtiter plate wells and subsequently transferred to antigencoated test wells using a multichannel pipetter. This resulted in rapid
transfer of samples to antigen-coated test wells minimizing sample
incubation time variability on the test plate.
Antigen Capture ELISA-serum was performed using the same
commercial test kit on 100 µl of serum placed into antigen-coated test
wells. When testing >20 samples, low protein binding microtiter wells
and a multichannel pipetter were used to facilitate more rapid transfer
of samples to the antigen-coated test plate at nearly the same time, so
that samples did not incubate for variable times.
Real-time reverse transcriptase PCR for BVDV was performed as
described previously [12]. Specimens tested included bovine blood
collected into EDTA tubes and refrigerated, or fresh spleen, lymph
node, tonsil or mucosa-associated lymphoid tissues, either refrigerated
or frozen at -20°C. Primers and probes were obtained commercially
(Applied Biosystems, Inc., Foster City, CA) and were: forward primer
5’GGG NAG TCG TCA RTG GTT CG3’; reverse primer 5’GTG CCA
TGT ACA GCA GAG WTT TT3; probe 5’- 6 -FAM- CCA YGT GGA
CGA GGG CAY GC [BHQ]3’. These primers amplify a 190 bp
fragment in both BVDV type I and BVDV type II viruses. Following
RNA extraction and PCR, interpretation of results was: if a sample
exhibited amplification with Ct <38 cycles, and positive and negative
controls performed correctly, the sample was classified as BVDV
detected [12]. If no sample amplification curve was observed, or the
amplification curve crossed the threshold with Ct >38, and positive
and negative controls performed correctly, the sample was classified as
BVDV not detected.
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Electronic capture of data
Signalment and laboratory findings were entered into a laboratory
information management system (Vetstar Animal Disease Diagnostic
System [VADDS], Advanced Technology Corporation, Ramsey, NJ,
USA) and transferred into data fields in a commercial database
program (Excel, Microsoft Corporation, Redmond, WA). Data fields
populated were accession number, date, animal ID, BVDV test
method, test result, breed, age in days, age category and sex. Totals by
category were calculated.

Statistical analysis
This is an observational study reporting diagnostic results; it was
not a planned experiment, or even a natural experiment. The case
could be made that no statistical analysis should be done for
differences in BVD prevalence among the different types of samples or
populations, such as aborted fetuses, necropsies, serum or ear notches.
However, for the sake of interest, to supplement each reader’s
judgement of whether differences are biologically important, statistical
analysis was performed. Comparison among animal or test method
categories for proportion with BVDV “detected” or “not detected” was
evaluated for statistical significance using Chi-square. Critical value of
P for statistical significance was α=0.05.

Results
There were 8,975 samples of bovine origin tested for BVDV during
the study period. The virus was detected in 105/8,975 samples (1.2%).
Test methods, the proportion of BVDV detected results for each type
of test, and results by age, sex, or breed are shown in Tables 1 and 2.
Specimens in two categories were significantly more likely to have
BVDV detected: necropsied animals (22/180; 12.2%) (P<0.0001) and
those tested with PCR (7/88; 8.0%) (P<0.0001), in comparison to
specimens tested using Ag Capture ELISA-skin (79/7,692; 1.0%) or
using Ag Capture ELISA-serum (19/1,195; 1.6%). A trend (P=0.07)
was observed that dairy breeds (25/750; 3.3%) were more likely to be
detected with BVDV than beef breeds (26/1600; 1.6%). There were no
significant differences in BVDV detection by age or sex.
Table 1: Results by BVDV test method applied to bovine samples.
BVDV Test Method

Tested (n)

BVDV Detected (n) (%)

Ag Capture ELISA-skin

7,692

79 (1.0%)

Ag Capture ELISA-serum

1,195

19 (1.6%)

PCR

88

7 (8.0%)*

180

22 (12.2%)*

Necropsy (all

methods)£

£: Subset of above 3 categories. *Higher prevalence of “BVDV
detected” results in comparison with skin (usually ear notch) and
serum samples, P<0.0001.
The breed of the tested animal was provided by submitters or
determined at necropsy for 2,350 animals. Dairy breeds (n=750)
consisted of: 713 Holsteins (95.1%), 29 Jerseys (3.9%), 7 Milking
Shorthorns (0.9%), and 1 Ayrshire (0.1%). Beef breeds (n=1,600)
consisted of: 959 Angus (59.9%), 365 “Beef ” (22.8%), 99 Hereford
(6.2%), 63 Red Angus (3.9%), 54 Charolais (3.4%), 42 Simmental
(2.6%), 5 Corriente (0.3%), 4 Longhorn (0.3%), 4 Belted Galloway
(0.3%), 1 Beefmaster (0.1%), 1 Maine Anjou (0.1%) and 1 Watusi
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(0.1%). The sex of tested animals was provided by submitters or
determined at necropsy for 597 animals, 382 females (64.0%) and 215
males (36.0%).
Table 2: BVDV test results by sex, age, and dairy vs. beef breeds.
Age, Sex or Breed

Tested (n)

BVDV Detected (n) (%)

Male

215

5 (2.3%)£

Female

382

9 (2.4%)£

Fetus

36

3 (8.3%)£≠

Calf (1-200 days)

579

29 (5.0%)£¥

Juvenile (201-729 days)

183

4 (2.2%)£γ

Adult (≥ 730 days)

75

4 (5.3%)£ λ

Dairy€

750

25 (3.3%)+

Beef±

1,600

26 (1.6%)+

£: No significant difference among sex, age, or by test method within
sex, age or breed. ≠All 3 by PCR at necropsy. ¥27 by Ag Capture ELISAskin, including 16 of 114 necropsies (14.0%). γ3 by Ag Capture ELISA
- serum, 1 by Ag Capture ELISA- skin, of 6 necropsies (16.7%). λ2 by
Ag Capture ELISA-serum, 2 by Ag Capture ELISA- skin, of 24
necropsies (8.3%). €95.1% Holsteins, 3.9% Jerseys. ±59.9% Angus,
22.8% “Beef ”. +P = 0.07.

Discussion
As is true of samples submitted to any veterinary diagnostic
laboratory, diagnostic samples in this study were of different types,
such that the expected likelihood of detecting BVD differed between
them. Necropsy specimens were tested for BVDV only if lesions
suggested infection with the virus. Therefore, the prevalence of BVDV
among all necropsied bovines was not determined, but the virus was
detected in a relatively high proportion (approximately 12%) of suspect
cases, as would be expected. A previous survey of US veterinary
diagnostic laboratories reported that laboratories self-identified as
predominantly testing samples from animals suspected to have BVDV
had 6.6% BVDV-positive tests and those that tested mainly BVDV
screening samples had 1.0% positive tests [9]. No detection of BVDV
in the majority of animals tested based on suspicion of the disease at
necropsy may be attributable to failure of the virus to survive after
death of the host even when infection had been present. In addition,
bovine coronavirus and bovine rotavirus in calves and malignant
catarrhal fever in any age animal may mimic BVDV-induced lesions in
cattle [1].
Because PCR tests were only performed on suspect necropsy
specimens, it is not surprising that PCR resulted in relatively high
proportion of BVDV detection. Samples collected at necropsy had
BVDV detected at 80 to 100 times the 0.1% reported as overall
prevalence of BVDV, but the latter focuses primarily on PI prevalence
rather than that of transiently infected animals [11,13,14]. However,
virus detection in the high-volume screening samples tested by ELISA
that made up the majority of samples in this case series occurred at 10
times the 0.1% reported prevalence of PI animals [11]. Prevalence rates
of cattle that may be transiently infected with BVDV at any given time
are not well described. The relatively high proportion of detection of
BVDV reported in the current study is similar to that in a previous
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survey of US diagnostic laboratories, which found that BVDV was
detected in 4.3% of samples submitted for BVDV testing, ranging up to
26.1% for one laboratory [9]. Diagnostic laboratory samples, which
include a subset of necropsies performed because BVD is suspected,
might logically be expected to have more BVDV detected [9] than the
proportion of the disease reported in investigations of BVDV PI
prevalence that are not based on suspicion of BVD [11,13,14].
At the UVDL, the most commonly used BVDV test methods were
Ag capture ELISA on ear notches, followed by the same ELISA on
serum, while PCR constituted only about 1% of BVDV tests; this
agrees with a previous report of test methods used at other veterinary
diagnostic laboratories [9]. Sensitivity and specificity of diagnostic tests
or procedures are important in order to correctly classify animals
compared to their “true positive” or “true negative” disease status. In a
previous validation study of a BVDV ELISA that used the same
technology as the ELISA used in this study, 240 samples of serum or
whole blood from herds certified BVD-free and 197 samples detected
with BVDV using an NS3 (pestivirus protein) detecting ELISA were
tested. For all 437 samples, the “gold standard” to determine “true”
BVD-positive or BVD-negative status was an RT-PCR. Sensitivity of
the BVDV ELISA was 99% and specificity was 99.5% (compared with
PCR) [15]. The RT-PCR is often described as a highly accurate test for
BVDV, with sensitivity and specificity nearly 100% [16], but there are
no refereed scientific publications comparing it to “true” BVDV status,
and calculating test sensitivity or specificity. This is largely because of
the lack of an agreed upon standardized test or combination of tests to
be used as a “gold standard” to classify animals or samples as “true”
BVDV-positive or negative. However, the RT-PCR used in this study
has published data [12] comparing BVD test results to a combination
of other diagnostic tests including virus isolation and
immunohistochemistry, that allow calculation of both statistics. The
sensitivity was 60/61 (98.4%) and specificity was 2285/2290 (95.6%)
[12]. In our opinion, the “false positives” were inflated because the
other tests are not as sensitive as PCR; many of the 105 “false positive”
cases likely had BVD correctly detected by PCR only.
When the sex was determined or provided, approximately twothirds of the specimens were from females. This likely reflects that
bovine females outnumber males, and especially in the case of dairy
cattle, are often of greater financial value. When the breed was
determined or provided, the breeds of cattle tested were representative
of the proportions of dairy and beef breeds in the Intermountain West.
When prevalence of BVDV has been reported over the last 20 years,
it has focused on the 0.1% prevalence of PI cattle, but PI cattle are a
source of infection for large numbers of herdmates. The 8% BVDV
prevalence in aborted fetuses, 12% prevalence in necropsied cattle and
overall prevalence of >1% found in this study all indicate that BVDV
remains an important bovine disease in the Intermountain West of the
USA.
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